MELTEMI and COLUMBA: 5-Year Comparative Safety Analysis of Benralizumab and Mepolizumab

Authors:

Abstract
No abstract available
Funding Information
  • AstraZeneca (GPP 2022)

This publication has 31 references indexed in Scilit: